A phase I, multi-centre, randomised, placebo-controlled, dose escalation study to assess the local and systemic tolerability of the therapeutic DNA plasmid pdpSC18 vaccine administered by particle mediated epidermal delivery using the powderject ND 10 delivery system in subjects with chronic hepatitis B infection
Grant Data
Project Title
A phase I, multi-centre, randomised, placebo-controlled, dose escalation study to assess the local and systemic tolerability of the therapeutic DNA plasmid pdpSC18 vaccine administered by particle mediated epidermal delivery using the powderject ND 10 delivery system in subjects with chronic hepatitis B infection
Principal Investigator
Professor Yuen, Richard Man Fung
(Principal Investigator (PI))
Duration
12
Start Date
2006-11-01
Amount
30700
Conference Title
A phase I, multi-centre, randomised, placebo-controlled, dose escalation study to assess the local and systemic tolerability of the therapeutic DNA plasmid pdpSC18 vaccine administered by particle mediated epidermal delivery using the powderject ND 10 delivery system in subjects with chronic hepatitis B infection
Presentation Title
Keywords
Chronic Hepatitis B
Discipline
Gastroenterology/Hepatobiliary
HKU Project Code
N/A
Grant Type
PowderMed Ltd - General Award
Funding Year
2005
Status
On-going